logo 49 | The Camlog Partner Magazine Case study | 21 13. After completely guided preparation of the implant bed, the surface of the implant (CAMLOG PROGRESSIVE-LINE Ø 3.8 mm / L 13 mm) was biologized with PGRF. By modifying the surfaces with cell-biological, active substances, reactions are intended to be triggered to improve healing behavior in the bone. 14. The implant was also inserted completely guided via the GUIDE sleeve in the template. Deflection of the self-tapping implant is prevented by the guide and the implant is placed precisely three-dimensionally according to the planning. The stop of the insertion post on the sleeve ensures correct and slightly subcrestal positioning of the implant. 17. The X-ray control image illustrates anchorage of the apical implant portion in the residual jawbone and the approximately one millimeter subcrestal placement of the implant shoulder. 18. The implant was covered with an autologous fibrin matrix, which was applied compressed to the surgical site. A connective tissue graft did not prove necessary in this case. A single button suture was used to stabilize the mesial papilla. 15. The implant was placed in the palatal region of the alveolus and anchored in the jawbone with sufficient primary stability via the conical apical portion. Positioning allowed the hybrid crown to be screw-retained in the palatal surface of regio 22. 16. The cavity between the implant and the buccal lamella (jumping distance) was filled with xenogeneic bone graft substitute (The GraftTM / Regedent) mixed with PRGF (BTI) to stabilize the alveolar wall.
RkJQdWJsaXNoZXIy MTE0MzMw